These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 7498267)

  • 1. Studies of four novel diphenylbutylpiperazinepyridyl derivatives on release and inhibition of reuptake of dopamine, serotonin and noradrenaline by rat brain in vitro.
    Pettersson E
    Eur J Pharmacol; 1995 Aug; 282(1-3):131-5. PubMed ID: 7498267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amperozide, a putative anti-psychotic drug: uptake inhibition and release of dopamine in vitro in the rat brain.
    Eriksson E
    Life Sci; 1990; 47(23):2111-7. PubMed ID: 1979998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5-HT1A autoreceptor-mediated effects of the amperozide congeners, FG5865 and FG5893, on rat brain 5-hydroxytryptamine neurochemistry in vivo.
    Hjorth S; Pettersson G
    Eur J Pharmacol; 1993 Jul; 238(2-3):357-67. PubMed ID: 7691622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preclinical pharmacology of FG5893: a potential anxiolytic drug with high affinity for both 5-HT1A and 5-HT2A receptors.
    Albinsson A; Björk A; Svartengren J; Klint T; Andersson G
    Eur J Pharmacol; 1994 Aug; 261(3):285-94. PubMed ID: 7813550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serotonin-stimulated release of [3H]dopamine via reversal of the dopamine transporter in rat striatum and nucleus accumbens: a comparison with release elicited by potassium, N-methyl-D-aspartic acid, glutamic acid and D-amphetamine.
    Jacocks HM; Cox BM
    J Pharmacol Exp Ther; 1992 Jul; 262(1):356-64. PubMed ID: 1352552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alcohol intake in high alcohol drinking (HAD) rats is suppressed by FG5865, a novel 5-HT1A agonist/5-HT2 antagonist.
    Long TA; Kalmus GW; Björk A; Myers RD
    Pharmacol Biochem Behav; 1996 Jan; 53(1):33-40. PubMed ID: 8848457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antidepressant-like effects of novel triple reuptake inhibitors, PRC025 and PRC050.
    Shaw AM; Boules M; Zhang Y; Williams K; Robinson J; Carlier PR; Richelson E
    Eur J Pharmacol; 2007 Jan; 555(1):30-6. PubMed ID: 17109850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GBR 12783, a potent and selective inhibitor of dopamine uptake: biochemical studies in vivo and ex vivo.
    Bonnet JJ; Costentin J
    Eur J Pharmacol; 1986 Feb; 121(2):199-209. PubMed ID: 3754516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of duloxetine, an antidepressant drug candidate, on concentrations of monoamines and their metabolites in rats and mice.
    Fuller RW; Hemrick-Luecke SK; Snoddy HD
    J Pharmacol Exp Ther; 1994 Apr; 269(1):132-6. PubMed ID: 7513356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p-methylthioamphetamine is a potent new non-neurotoxic serotonin-releasing agent.
    Huang X; Marona-Lewicka D; Nichols DE
    Eur J Pharmacol; 1992 Dec; 229(1):31-8. PubMed ID: 1473561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of some quinolizidine derivatives on the release of serotonin, noradrenaline, dopamine and acetylcholine from rat brain synaptosomes.
    Sparatore A; Marchi M; Maura G; Raiteri M
    Farmaco; 1989 Dec; 44(12):1205-16. PubMed ID: 2634407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stereochemical effects of 3,4-methylenedioxymethamphetamine (MDMA) and related amphetamine derivatives on inhibition of uptake of [3H]monoamines into synaptosomes from different regions of rat brain.
    Steele TD; Nichols DE; Yim GK
    Biochem Pharmacol; 1987 Jul; 36(14):2297-303. PubMed ID: 2886126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preclinical pharmacology of TP1, a novel potent triple reuptake inhibitor with antidepressant properties.
    Tian JW; Jiang WL; Zhong Y; Meng Q; Gai Y; Zhu HB; Hou J; Xing Y; Li YX
    Neuroscience; 2011 Nov; 196():124-30. PubMed ID: 21925241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of chronic cocaine administration on [3H]dopamine uptake in the nucleus accumbens, striatum and frontal cortex of rats.
    Masserano JM; Venable D; Wyatt RJ
    J Pharmacol Exp Ther; 1994 Jul; 270(1):133-41. PubMed ID: 8035309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of a potent wide-spectrum serotonin-, norepinephrine-, dopamine-reuptake inhibitor (SNDRI) and a species-selective dopamine-reuptake inhibitor based on the gamma-amino alcohol functional group.
    Carlier PR; Lo MM; Lo PC; Richelson E; Tatsumi M; Reynolds IJ; Sharma TA
    Bioorg Med Chem Lett; 1998 Mar; 8(5):487-92. PubMed ID: 9871604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2-Substituted N-aryl piperazines as novel triple reuptake inhibitors for the treatment of depression.
    Carter DS; Cai HY; Lee EK; Iyer PS; Lucas MC; Roetz R; Schoenfeld RC; Weikert RJ
    Bioorg Med Chem Lett; 2010 Jul; 20(13):3941-5. PubMed ID: 20570146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carrier-dependent and Ca(2+)-dependent 5-HT and dopamine release induced by (+)-amphetamine, 3,4-methylendioxymethamphetamine, p-chloroamphetamine and (+)-fenfluramine.
    Crespi D; Mennini T; Gobbi M
    Br J Pharmacol; 1997 Aug; 121(8):1735-43. PubMed ID: 9283711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin.
    Rothman RB; Baumann MH; Dersch CM; Romero DV; Rice KC; Carroll FI; Partilla JS
    Synapse; 2001 Jan; 39(1):32-41. PubMed ID: 11071707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proceedings: The effect of mepiprazole on the uptake of norepinephrine, dopamine and serotonin into rat brain synaptosomes.
    Placheta P; Singer E; Krivanek W; Hertting G
    Naunyn Schmiedebergs Arch Pharmacol; 1975; 287 Suppl():R4. PubMed ID: 1143436
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of the d- and l-isomers of amphetamine on uptake, release and catabolism of norepinephrine, dopamine and 5-hydroxytryptamine in several regions of rat brain.
    Holmes JC; Rutledge CO
    Biochem Pharmacol; 1976 Feb; 25(4):447-51. PubMed ID: 938573
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.